15-year remission in refractory FLT3-mutated AML attained by sorafenib.

ABSTRACT:

SUBMITTER: Rummelt C 

PROVIDER: S-EPMC11534974 | biostudies-literature | 2024 Nov

REPOSITORIES: biostudies-literature